"Immune Monitoring : T cell mucin 1-specific responses
Analysis of three patients after the first three doses of CVac has shown a mucin 1-specific T cell response while no response was observed in normal healthy volunteers nor untreated patients ."
An early lead on the ICS result for the full 7 cohort trial, which could be out any time.
This seems to be just what we're hoping for, potential to move into other treatment markets.
ann out , page-4
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
30.8¢ |
Change
-0.008(2.38%) |
Mkt cap ! $450.9M | |||
| Open | High | Low | Value | Volume |
| 30.5¢ | 31.5¢ | 30.5¢ | $352.9K | 1.140M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 316004 | 30.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 31.0¢ | 101941 | 16 |
View Market Depth
| Last trade - 14.36pm 13/11/2024 (20 minute delay) ? |
| IMM (ASX) Chart |